ClinicalTrials.Veeva

Menu

Neuronal Excitability of HCN1 Channel Mutations in Dravet Syndrome (EXCIDRAH)

F

Fondation Ophtalmologique Adolphe de Rothschild

Status

Completed

Conditions

Dravet Syndrome

Treatments

Device: measure of neuronal excitability

Study type

Observational

Funder types

NETWORK

Identifiers

NCT02896608
AGN_2015_11

Details and patient eligibility

About

This study addresses the changes in the axonal excitability parameters. It will compare these changes in patients with early infantile epileptic encephalopathy with HCN1 channel mutation and in control patients, with and without epilepsy.

Enrollment

92 patients

Sex

All

Ages

15+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • early infantile epileptic encephalopathy with HCN1 channel mutation
  • control patients with no neurologic pathology (age, gender and body temperature matched)
  • epileptic patients (age, gender and body temperature matched)

Exclusion criteria

  • pregnant or breast feeding patient

Trial design

92 participants in 3 patient groups

Dravet syndrome - HCN1 channel mutation
Description:
early infantile epileptic encephalopathy with HCN1 channel mutation
Treatment:
Device: measure of neuronal excitability
control with epilepsy
Treatment:
Device: measure of neuronal excitability
control without epilepsy
Treatment:
Device: measure of neuronal excitability

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems